BerandaNVZMF • OTCMKTS
add
Novozymes A/S
Tutup sebelumnya
$65,63
Rentang hari
$67,17 - $68,84
Rentang tahun
$53,55 - $71,52
Kapitalisasi pasar
187,04Â M DKK
Volume Rata-Rata
2,07Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,08Â M | 26,26% |
Biaya operasional | 318,60Â jt | 26,73% |
Laba bersih | 186,00Â jt | 458,56% |
Margin laba bersih | 17,26 | 342,56% |
Penghasilan per saham | 3,14 | — |
EBITDA | 412,80Â jt | 31,76% |
Tarif pajak efektif | 23,99% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 249,50Â jt | 66,67% |
Total aset | 15,06 M | — |
Total liabilitas | 3,83 M | — |
Total ekuitas | 11,23 M | — |
Saham yang beredar | 466,19 jt | — |
Harga terhadap nilai buku | 2,72 | — |
Tingkat pengembalian aset | 4,56% | — |
Tingkat pengembalian modal | 5,32% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 186,00Â jt | 458,56% |
Kas dari operasi | 106,40Â jt | -39,72% |
Kas dari investasi | -38,30Â jt | -25,57% |
Kas dari pembiayaan | -102,10Â jt | -13,57% |
Perubahan kas bersih | -30,50Â jt | -148,34% |
Arus kas bebas | 63,55 jt | — |
Tentang
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
CEO
Didirikan
2000
Situs
Karyawan
10.582
